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Abstract Two cDNAs for possible splicing variants of a 74-
kDa regulatory subunit (B" or δ) of human protein phosphatase 
2A, were isolated. These variants were identified from human 
cerebral cortex by library screening and PCR, and designated 61 
and S3 isoforms, while the previously reported isoform [Tanabe et 
al. (1996) FEBS Lett. 379, 107-111] was designated 52. 
Compared with the 62 isoform, the 51 isoform contained a 32-
residue insertion beginning at residue 84, and consisted of 602 
amino acids in all. The 53 isoform lacked a 74-residue sequence 
corresponding to residues 1083 of the 52 isoform, and consisted 
of 496 amino acids. Using isoform-specific antipeptide antisera, 
the 74-kDa subunit (B" or δ) originally purified from human 
erythrocytes was identified as the 51 isoform. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Protein phosphatase 2A (PP2A), one of the four major 
protein serine/threonine phosphatases, is found in all eukar-
yotes, and plays crucial roles in the regulation of many cellu-
lar processes including metabolism, cell cycle, DNA replica-
tion, transcription, translation, and viral transformation [1,2]. 
PP2A holoenzymes with either a heterodimeric or a heterotri-
meric subunit structure have been purified from various mam-
malian tissues and organisms. The heterodimeric structure is 
composed of a 32-41-kDa catalytic C subunit and a 60-69-
kDa regulatory A subunit. The AC heterodimer is a common 
component of all PP2A holoenzymes identified to date. The 
trimeric holoenzyme contains an additional variable regula-
tory subunit of either 51-58-kDa B [1,3], 54-kDa B' [4], 72-
kDa PR72 [5], or 74-kDa δ (also called B") [6]. Molecular 
cloning of these subunits has revealed that these variable sub-
units are classified into three unrelated families, namely, B [7-
10], PR72 [11], and B' families. The B' family was identified 
most recently, and found to be encoded by five distinct genes 
that produce several splicing variants [12-17]. 
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The nucleotide sequences reported in this paper have been submitted to 
the DDBJ, EMBL and GenBank databases with accession numbers 
AB000634 (51) and AB000635 (53). 
From human erythrocyte cytosol, we purified three forms of 
PP2A whose subunit structures are αιβι, αιβιγι, and (Χιβιδι, 
where a corresponds to the catalytic C subunit, and β, γ, and 
δ correspond to the A, B, and B" regulatory subunits, respec-
tively [6]. Based on partial amino acid sequences of the δ (Β") 
subunit, its cDNA was isolated from human cerebral cortex 
and bone marrow cDNA libraries [12]. Recent molecular 
cloning of the B' [14,15], B56 [13,17], and PR61 [16] subunits 
of PP2A has revealed that these subunits and the δ (Β") sub-
unit have strong sequence similarity, especially in the central 
400-amino acid region of the molecules with more than 70% 
identity, and comprise a new family of the regulatory subunit 
of PP2A, the B' family. The predicted primary structure of the 
δ (Β") subunit is most similar to that of human Β56δ among 
the family members, and different only by a 32-amino acid 
insertion in Β56δ near the N terminus [12,17]. The predicted 
primary structure of the δ (Β") subunit is also similar to rabbit 
Β'γ, which contains the same 32-amino acid insertion and a 
unique N-terminal 4-residue sequence instead of the N-termi-
nal 20-residue sequence in the δ subunit [12,14]. Comparison 
of the nucleotide sequences of the cDNAs for the human δ 
(B"), Β56δ, and rabbit Β'γ subunits suggests that they may be 
generated by alternative splicing. The variable regulatory sub-
units of PP2A have been suggested to play the roles of regu-
lating the activity, and determining the substrate specificity 
and the intracellular localization of PP2A [1,2]. Therefore, 
characterization of each regulatory subunit is necessary for 
better understanding of the function and regulation of PP2A. 
In this study, we identified two isoforms of the δ (Β") sub-
unit possibly generated by alternative splicing, designated δΐ 
and δ3, while the previously reported isoform [12] was desig-
nated δ2. Compared with the δ2 isoform, the δΐ isoform con-
tained a 32-amino acid insertion near the N terminus, and was 
identical with Β56δ [17]. The δ3 isoform lacked a 74-amino 
acid sequence found in the δ2 isoform. Using specific antisera 
raised against peptides which have the δΐ-specific insertion 
sequence and the N-terminal sequence common to the δ1/δ2 
isoforms, the 74-kDa δ (Β") subunit originally purified from 
human erythrocytes was identified as the δΐ isoform. 
2. Materials and methods 
2.1. Amplification of b cDNAs by PCR 
Initial amplification of the 5' end fragments of the δ cDNAs from 
HeLa cell cDNA and human cerebral cortex cDNA (Clontech) was 
achieved by PCR with δ-specific primers, 5'-GCGGATCCATGCCC-
TATAAACTGAAA-3' (forward primer, DF1) and 5'-TGAAAA-
CATGGTGACAGC-3' (reverse primer, DR1) corresponding to nu-
cleotides 78-95 and 492-509, respectively (Fig. 1). The nucleotide 
numbers are based on the 52 cDNA sequence reported previously 
[12]. The reactions were carried out in a volume of 50 μΐ containing 
20 mM Tris-HCl, pH 8.8, 10 mM KC1, 10 mM (NH4)2S04, 2 mM 
MgS04, 0.1% Triton X-100, 0.1 mg/ml bovine serum albumin, 0.2 
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Fig. 1. Structures of cDNAs for three isoforms of the human 8 (Β") 
subunit of PP2A. The cDNAs for the 51 and 83 isoforms were iso-
lated from human cerebral cortex by library screening and PCR. 
The cDNA for the 82 isoform was previously isolated from the hu-
man cerebral cortex cDNA library [12]. The open reading frames 
are shown as boxes, and poly(A) tails are shown as (A)n. The 
angled lines in the 52 and 83 cDNAs indicate deletions. The arrows 
indicate the positions and directions of the primers used for PCR. 
The restriction sites for Apal (A), Hindlll (H), BamHl (B), Sad 
(S), and Kpnl (K) are indicated. 
mM deoxynucleoside triphosphates, 0.2 μΜ forward and reverse pri-
mers, 1.25 units of Taq polymerase (Boehringer), and 1.25 units of 
Taq Extender PCR Additive (Stratagene) with 35 amplification cycles, 
each consisting of 30 s denaturation at 95°C, 30 s annealing at 54°C, 
and 90 s extension at 72°C. Amplified fragments were separated in 
ethidium bromide-stained 1.5% agarose gel, purified with DEAE-cel-
lulose membrane (Schleicher and Schuell), and cloned into the pUC19 
plasmid for sequence analysis. 
Isolation of the whole coding region of the 83 cDNA from human 
cerebral cortex cDNA was achieved by PCR with another set of 8-
specific primers, 5'-GCTCTAGAGCCGGAGCGGGGCCGCAG-
GA-3' (forward primer, DF2) and 5'-GCGAATTCGGAGGGC-
CAGGGCAGTGTCCCA-3' (reverse primer, DR2) corresponding 
to nucleotides 30-51 and 1832-1853, respectively, in the untranslated 
regions of the 82 cDNA (Fig. 1). The reaction was carried out in the 
same mixture as described above with 35 amplification cycles, each 
consisting of 30 s denaturation at 94°C, and 3 min annealing with 
extension at 68°C. Amplified fragments were separated in 1.0% agar-
ose gel, and cloned into the pUC19 plasmid for sequence analysis. The 
sequences were determined on both strands using the AutoRead se-
quence kit (Pharmacia) and A.L.F. DNA Sequencer II (Pharmacia). 
The underlined sequences in the primers are restriction sites intro-
duced for cloning the PCR products into plasmids. 
1 CCGGACGGGCCGAGATGCCCTATAAACTGAAAAAGGAGAAGGAGCCCCCCAAGGTTGCCAAATGCACAGCCAAGCCTAGCAGCTCGGGCAAGGATGGTGGAGGC 104 
1 M P Y K L K K E K E P P K V A K C T A K P S S S G K D G G G 30 
A A 
105 GAGAACACTGAGGAGGCCCAGCCGCAGCCCCAGCCCCAGCCCCAGCCCCAAGCCCAGTCTCAGCCACCGTCATCCAACAAGCGTCCCAGCAATAGCACGCCGCCC 209 
3 1 E N T E E A Q P Q P Q P Q P Q P Q A Q S Q P P S S N K R P S N S T P P 65 
Δ 
210 CCCACGCAGCTCAGCAAAATCAAGTACTCAGGGGGGCCCCAGATTGTCAAGAAGGAGCGACGGCAAAGCTCCTCCCGCTTCAACCTCAGCAAGAATCGGGAGCTG 314 
66 K I K V K K R R N K N R S 3 S R 
M\ ib. 
315 CAGAAGCTTCCTGCCCTGAAAGAITCGCCAACCCAGGAGCGGGAGGAGCTGTTTATCCAGAAGCTACGCCAGTGCTGTGTCCTCTTTGACITCGTGTCAGACCCA 
1 0 1 Q K L P A L K D S P T Q E R E E L E I Q K L R Q C C V L F D F V S D P 
100 
419 
135 
420 CTCAGTGACCTCAAATTCAAGGAGGTGAAGCGGGCAGGACTCAACGAGATGGTGGAGTACAICACCCATAGCCGIGATGTTGTCACTGAGGCCATTTACCCTGAG 
136 L S D L K F K E V K R A G L N E M V E Y I T H S R D V V T E A I Y P E 
524 
170 
525 GCTGTCACCATGTTTTCAGTGAACCTCTTCCGGACGCTGCCACCTTCATCGAATCCCACAGGGGCTGAGTTTGACCCAGAGGAAGATGAGCCCACCCTGGAAGCT 
171 A V T M F S V N L F R T L P P S S N P T G A E F D P E E D E P T L E A 
62 9 
205 
630 GCTTGGCCACATCTCCAGCTCGTGTATGAGTTCTTCT1ACGTTTCCTTGAGTCTCCTGATTTCCAGCCAAACATAGCCAAGAAGTACATCGACCAGAAGTTTGTA 
206 A W P H L Q L V Y E F F L R F L E S P D F Q P N I A K K Y I D Q K F V 
734 
240 
735 CTTGCTCTCCTAGACCTATTTGACAGTGAGGATCCTCGAGAGCGGGACTTCCTCAAGACCATTTTGCATCGCATCTATGGCAAGTTTTTGGGGCTCCGGGCTTAT 
241 L A L L D L F D S E D P R E R D F L K T I L H R I Y G K F L G L R A Y 
839 
275 
84 0 ATCCGTAGGCAGATCAACCACATCTTCTACAGGTTCATCTACGAGACGGAGCATCACAACGGGATTGCTGAGCTCCTGGAGATCCTGGGCAGCATCATCAATGGC 
27 6 I R R Q I N H I F Y R F I Y E T E H H N G I A E L L E I L G S I I N G 
944 
310 
94 5 TTTGCCCTGCCCCTTAAAGAAGAGCACAAGATGTTCCTCATCCGTGTCCTACITCCCCTTCACAAGGTCAAGTCCCIGAGTGICTACCACCCTCAGCTGGCATAC 104 9 
311 F A L P L K E E H K M F L I R V L L P L H K V K S L S V Y H P Q L A Y 345 
1050 TGTGTGGTACAATTCCTGGAGAAGGAGAGCAGTCTGACTGAGCCGGTAATTGTGGGACTTCTCAAGTTTTGGCCCAAGACCCACAGCCCCAAGGAGGTGATGTTC 1154 
346 C V V Q F L E K E S S L T E P V I V G L L K F W P K 1 H S P K E V M F 380 
Á 
1155 TTGAATGAGCTGGAGGAGATTCTGGACGTCATTGAACCTTCTGAGTTCAGCAAAGTGATGGAACCCCTCTTCCGCCAGCTGGCCAAGTGTGTCTCTAGCCCCCAT 1259 
381 L N E L E E I L D V I E P S E F S K V M E P L F R Q L A K C V S S P H 415 
12 60 TTCCAGGTGGCAGAGCGTGCTCTCTATTACTGGAACAATGAGTACATCATGAGCCTGATAAGTGACAATGCTGCCCGAGTCCTCCCCATCATGTTCCCTGCACTC 1364 
416 F Q V A E R A L Y Y W N N E Y I M S L I S D N A A R V L P I M F P A L 450 
1365 TACAGGAACTCCAAGAGCCACTGGAACAAGACAATCCATGGACTGATCTATAATGCCCTGAAGTTGTTTATGGAAATGAATCAGAAGCTGTTTGAIGACTGCACA 14 69 
451 Y R N S K S H W N K T I H G L I Y N A L K L F M E M N Q K L F D D C T 485 
1470 CAACAATACAAGGCAGAGAAGCAGAAGGGCCGGTTCCGAATGAAGGAAAGGGAAGAGATGTGGCAAAAAATCGAGGAGCTGGCCCGGCTTAATCCCCAGTATCCC 1574 
486 Q Q Y K A E K Q K G R F R M K E R E E M W Q K I E E L A R L N P Q Y P 520 
1575 ATGTTCCGAGCCCCTCCACCACTGCCCCCTGTGTACTCGATGGAGACAGAGACCCCCACAGCTGAGGACATCCAGCTTCTGAAGAGGACTGTGGAGACTGAGGCT 167 9 
521 M F R A P P P L P P V Y S M E T E T P T A E D I Q L L K R T V E T E A 555 
1680 GTTCAGATGCTAAAAGACATCAAGAAGGAGAAAGTGCTGCTGCGGAGGAAGTCGGAGCTGCCCCAGGACGTGTACACCATCAAGGCACTGGAGGCGCACAAGCGG 178 4 
556 V Q M L K D I K K E K V L L R R K S E L P Q D V Y T I K A L E A H K R 590 
Δ 
1785 GCGGAAGAGTTCCTAACTGCCAGCCAGGAGGCTCTCTGACCCCTCACGTTCCTACCACAGGGCCACAGCCCACACAGCCCTGGGACACTGCCCTGGCCCTCCATA 188 9 
5 9 1 A E E F L T A S Q E A L * 602 
1890 CTCTGCTCCCTACTGGCTGTCTTGGGGGAAGGCAGCGCCTCTCTAGCTACTCAAGGGAGGGGGATGIGGGCACTTGAAGCAGGGACACCCACAGAATGGTCCCTC 1994 
1995 TTCTCCCCAAAAGGTGTTCATGCCTCCCTGTGGCTAGTACAGGCTGAGCACTAAGATGCTTAGTGCTCAGACAACCTGGGGATGCCTGTCCCCTACCIGCTCCTC 20 9 9 
2100 ACCCACAGCTACCTGAGGCTGCTCTGAGAAGTACACACAGGAATACATACGCTCCTCTATTCTTCCCTTCATCCTCATTTGAACGCCAGGTATCTCCCCTCCTCT 2204 
2205 CTCTCCCCTGCAG 2217 
Fig. 2. Nucleotide and deduced amino acid sequences of the 81 cDNA. The 82 cDNA lacked the region indicated with the double underline. 
The 63 cDNA lacked the region indicated with the single and double underlines. The asterisk represents the stop codon. The dotted lines indi-
cate the sequences used for production of the antipeptide antisera. Potential phosphorylation sites for protein kinase A (Δ) and protein kinase 
C ( A ) are indicated [18]. 
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2.2. Production of antipeptide antisera 
The N-terminus peptide, MPYKLKKEKEPPKVC, consisting of a 
sequence from residues 1-14 of the δ1/δ2 isoforms and an additional 
cysteine residue (underlined), and the insertion peptide, 
CKNRELQKLPALKDSPT, consisting of a sequence from residues 
96-111 of the 81 isoform and an additional cysteine residue (under-
lined), were synthesized (TANA Laboratories). The peptides were 
coupled to KLH through the cysteine residue using MBS as a cou-
pling reagent. Sixteen milligrams of KLH was dissolved in 1 ml of 10 
mM sodium phosphate buffer, pH 7.2, and then mixed with 2.8 mg of 
MBS dissolved in 10 μΐ of dimethylformamide. The reaction mixture 
was incubated for 30 min at room temperature with stirring, and 
passed through a Sephadex G-25 column (40x1.0 cm). The protein 
peak was collected, and one-tenth of the solution (0.7 ml) was mixed 
with 0.35 ml of 0.2 M sodium phosphate buffer, pH 7.2 and 1 mg of 
the synthetic peptide dissolved in 0.5 ml of distilled water. The reac-
tion mixture was incubated in N2 gas for 3 h at room temperature 
with continuous rotation. The KLH-peptide conjugates (0.2 mg pep-
tide) were emulsified in Freund's complete adjuvant, and then injected 
subcutaneously into New Zealand White rabbits. Three additional 
booster injections of KLH-peptide conjugates (0.1 mg peptide) emul-
sified in Freund's incomplete adjuvant were given at 2 to 4-week 
intervals. Enzyme-linked immunosorbent assay was used to screen 
for antipeptide antisera using the peptide antigens. Sera were collected 
2 weeks after the third booster injections. 
2.3. Bacterial expression and Western blot analysis 
The 51 and δ2 isoforms were expressed in bacteria using the 
pKK233-2 vector (Clontech). The ρΚΚ233-2-δ2 plasmid carrying 
the protein coding sequence of the 62 cDNA was described previously 
[12]. A pKK233-2-51 plasmid carrying the δΐ cDNA was constructed 
by replacing a 570-bp Apal-Sacl fragment in ρΚΚ233-2-δ2 with a 
666-bp Apal-Sacl fragment in the 61 cDNA (Fig. 1). The constructs 
were verified by sequencing. Escherichia coli DH5a cells were trans-
formed with these constructs and grown in Luria-Bertani medium 
supplemented with 100 μg/ml ampicillin at 37°C until OD60o was 
0.50. The bacteria were further incubated for 2 h with 1 mM isopro-
pylthio-ß-D-galactoside. From 3 ml of the culture, cells were collected 
by centrifugation, lysed in 0.3 ml of SDS-sample buffer (10 mM Tris-
HC1, pH 7.8, 3% SDS, 5% glycerol, 2.5 mM dithiothreitol, 0.0167% 
bromophenol blue), and then heated in a boiling water bath for 3 min. 
After centrifugation at 11 000 X g for 1 min, 27 μΐ of the supernatants 
was mixed with 3 μΐ of 0.63 M iodoacetamide, and then subjected to 
SDS-PAGE with 10% polyacrylamide gel. After electrophoresis, pro-
teins in the gels were electrophoretically transferred to polyvinylidene 
difluoride membranes (Millipore) and then probed with antibodies as 
described previously [12]. The rabbit antipeptide antisera diluted 8000-
fold were used as the primary antibody, and goat anti-rabbit IgG 
antibody conjugated to horseradish peroxidase (Kirkegaard and 
Perry) was used as the secondary antibody. Immunoreactive proteins 
on the membranes were detected with an enhanced chemiluminescence 
system (Amersham). 
3. Results and discussion 
Based on partial amino acid sequences of a 74-kDa regu-
latory subunit (B" or δ) of human erythrocyte PP2A, the 
cDNA was isolated from human cerebral cortex and bone 
marrow cDNA libraries [12]. The differences in the predicted 
primary structure near the N terminus between the human δ 
(B") subunit and its possible rabbit counterpart, the Β'γ sub-
unit [14], prompted us to search for other variants of the δ 
(B") subunit in the cDNA clones already isolated from the 
human cerebral cortex library. Of the 29 δ (Β") cDNA clones 
obtained by screening 1.3 X 106 plaques, 20 clones showed the 
same restriction maps as that of the clone C O . 1.3 reported 
previously [12]. However, 9 clones contained inserts with a 
different restriction map near 5' ends (Fig. 1). One of these 
clones, CC6.2.2, about 3.0 kb long, was subjected to sequence 
analysis. The nucleotide sequence of the whole coding region 
was determined, and shown to be different from C O . 1.3 only 
Fig. 3. Detection of δ cDNAs by PCR. Human HeLa cell and cere-
bral cortex cDNAs were subjected to PCR with the δ-specific pri-
mers (DFl and DRl) as described in Section 2. Five microhters of 
each reaction mixture was resolved on a 1.5% agarose gel stained 
with ethidium bromide (0.5 μg/ml). Positions of the PCR products 
are indicated with the arrow heads. The migration of molecular size 
standards (bp) is indicated to the left of the panel. 
by an in-frame 96-bp insertion found in CC6.2.2 near the 5' 
end (Fig. 2). This newly identified clone appeared to be an 
alternative splicing variant of the δ (Β") subunit, and was 
designated δΐ, while the previously identified cDNA was des-
ignated δ2. The δΐ cDNA contained a 1806-bp open reading 
frame encoding a protein of 602 amino acids with a calculated 
molecular weight of 69947 (Fig. 2). The deduced primary 
structure of the δΐ isoform was different from that of δ2 
only by a 32-amino acid insertion in δΐ beginning at residue 
84. The nucleotide sequence of the δΐ cDNA was identical 
with that of human Β56δ reported recently [17], except one 
base substitution in the coding region without any difference 
in the predicted primary structure. The rabbit Β'γ subunit is 
nearly identical with the δΐ isoform except that Β'γ contains a 
unique N-terminal 4-residue sequence instead of a 20-residue 
sequence of 51, and appears to be another splicing variant of 
the δ subunit [14]. 
To confirm the expression of two different δ mRNAs, PCR 
was performed with δ-specific primers, DFl and DRl , corre-
sponding to the sequences common to the δΐ and δ2 cDNAs, 
using human HeLa cell and cerebral cortex cDNAs as tem-
plates (Fig. 1). These primers were designed to sandwich the 
δΐ-specific insertion and to yield products of different sizes 
from the δΐ and δ2 cDNAs. Fragments of about 540 bp 
and 440 bp, which coincide with the expected products from 
the δΐ and δ2 mRNAs, respectively, were amplified from both 
templates (Fig. 3). Identification of these fragments with the 
δΐ and δ2 cDNAs was verified by subcloning and sequencing 
(data not shown). In addition to them, a smaller fragment of 
about 220 bp was amplified from both templates. This frag-
ment was also cloned into the pUC19 plasmid, and shown to 
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Fig. 4. Immunoblotting of bacterially expressed δΐ and 52 isoforms and the 74-kDa δ (Β") subunit from human erythrocytes using the antipep-
tide antisera. Immunoblots are shown of extracts from bacteria transformed by the pKK233-2 plasmids carrying the 51 cDNA (pKK233-2-51, 
lanes 2 and 6) and the 52 cDNA (pKK233-2-52, lanes 3 and 7), and the vector only (lanes 4 and 8). Lanes 1 and 5 contain 50 ng of human er-
ythrocyte αιβιδι (ACB"). The immunoblots were probed with the antisera against the N-terminus peptide (lanes 1-4) and the insertion peptide 
(lanes 5-8). The migration of molecular mass standards (kDa) is shown to the left of the panels. 
be identical with the δΐ and 52 cDNAs except a deletion in the 
fragment after 27th nucleotide from the initiation codon. This 
220-bp cDNA fragment seemed to be another splicing variant 
of the δ subunit, and was designated 53 (Figs. 1 and 2). 
In order to isolate the whole coding region of the 53 cDNA, 
we synthesized another set of δ-specific primers, DF2 and 
DR2, corresponding to the 5' and 3' untranslated regions of 
the 52 cDNA, respectively (Fig. 1). By PCR using these pri-
mers, the 53 cDNA of 1.6 kb, containing a sequence identical 
with the 220-bp fragment, was isolated from the human cer-
ebral cortex cDNA. The complete nucleotide sequence of the 
53 cDNA was determined with three independent clones, and 
shown to contain a 1488-bp open reading frame encoding a 
protein of 496 amino acids with a calculated molecular weight 
of 58415. The 53 cDNA was different from the 51 and 52 
cDNAs only by the deletion found in the 220-bp fragment 
(Figs. 1 and 2). The predicted primary structure of the 53 
isoform showed a deletion of residues 10-115 of the 51 iso-
form (Fig. 2). 
Comparison of the nucleotide sequences of the 51, 52, and 
53 cDNAs suggests that they may be generated by alternative 
splicing that joins different splice donor sites to a common 
acceptor site. The predicted amino acid sequences of the 52 
and 53 isoforms lacked 32- and 106-amino acid sequences 
found in the 51 isoform, respectively. In these regions, a clus-
ter of consensus phosphorylation sites for protein kinases A 
and C [18] and a unique glutamine-proline repeat [12] were 
identified (Fig. 2). The 74-kDa 5 (B,r) subunit in a holoenzyme 
was indeed phosphorylated by protein kinase A in vitro, re-
sulting in a slight increase in phosphatase activities toward 
phosphorylated histones and phosphorylase [19]. The epit-
ope-tagged overexpressed B565 was also shown to be phos-
phorylated in vivo [17]. These results suggest that the function 
of the 5 (B") subunit might be regulated in response to signals 
transduced by protein phosphorylation-dephosphorylation. 
To determine the isoform of the 74-kDa 5 (B") subunit 
originally purified from human erythrocytes, two isoform-spe-
cific antipeptide antisera were raised against synthetic peptides 
corresponding to the 16-residue sequence in the 51-specific 32-
residue insertion and the N-terminal 14-residue sequence com-
mon to the 51 and 52 isoforms. By Western blot analysis, the 
bacterially expressed 51 isoform was recognized by both anti-
sera, and the bacterially expressed 52 isoform reacted only 
with the antiserum against the N-terminus peptide (Fig. 4). 
The 74-kDa 5 (B") subunit was recognized by both antisera, 
and showed exactly the same electrophoretic mobility as the 
51 isoform expressed in bacteria. The bacterially expressed 52 
isoform showed slightly faster electrophoretic mobility than 
the 74-kDa 5 (B") subunit. These data indicate that the 74-
kDa 5 (B") subunit originally purified from human erythro-
cytes corresponds to the 51 isoform containing the 32-amino 
acid insertion. 
By this study, the number of possible splicing variants of 
the 5 subunit was brought to four, counting the rabbit Β'γ 
subunit [12,14,17]. The total number of the B' family isoforms 
has come to at least thirteen [12-17]. The diversity of the 
regulatory subunits may provide a molecular basis for so 
many important roles of PP2A in different cellular processes. 
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